跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Diovan - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Diovan
Approved
STANDARD
Diovan
Novartis Farmaceutica S.A.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c8be057ae7aad68b
Company
Novartis Farmaceutica S.A.
Type
Standard
Approval Details
Approval Id
c8be057ae7aad68b
Drug Approval Philippines Name
Diovan
Product Name
Diovan
Registration Number
DRP-5122
Brand Name
Diovan
Generic Name
Valsartan
Dosage Form
Tablet
Dosage Strength
320 mg
Manufacturer
Novartis Farmaceutica S.A.
Distributor
Novartis Healthcare Philippines, Inc.
Issuance Date
24 June 2022
Expiry Date
12 July 2027
Pharmacologic Category
Angiotensin II Receptor Blocker
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c8be057ae7aad68b
Type
Standard
Back to Philippines FDA Approvals